Skip to content

Validation and Characterization of Signal Decrease on an Oximeter in COPD (They Have Chronic Obstructive Pulmonary Disease) Patients During Deep Inhalation (

Validation and Characterization of Signal Decrease on an Oximeter in Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03966196
Acronym
OXYMETRE
Enrollment
12
Registered
2019-05-29
Start date
2019-02-11
Completion date
2019-05-10
Last updated
2019-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Copd, Pulmonary Disease

Keywords

COPD

Brief summary

The objective is to verify that there is a decrease in the pulsed oxygen saturation with the digital sensor. That is, the drop in oxygen saturation in COPD patients during inhalation is real and not due to an artifact of the measuring tool, because oximeters need a quality pulsatile signal to properly measure oxygen saturation

Interventions

OTHERMeasurements of oxygen saturation and finger pressure during deep inspiration

Measurements during deep inspiration of oxygen saturation with pulse oximeter and finger pressure with pressure cuff

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

half healthy subject, half COPD patients

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

healthy arm Inclusion Criteria: * Healthy adults volunteers are recruited from students with normal lung function.

Exclusion criteria

* abnormal lung function COPD Arm Inclusion Criteria: * Adults with Chronic Obstructive pulmonary disease

Design outcomes

Primary

MeasureTime frameDescription
drop in oxygen saturation during deep inspiration in COPDfrom the intervention to 3 minutes after the start of the interventionsaturation is measured in percentage (SPO2)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026